Browse > Article

Primary Malignant Peritoneal Mesothelioma Mimicking Peritoneal Carcinomatosis on F-18 FDG PET/CT  

Kim, Jin-Suk (Department of Nuclear Medicine, Chonbuk National University Medical School and Hospital)
Lim, Seok-Tae (Department of Nuclear Medicine, Chonbuk National University Medical School and Hospital)
Jeong, Young-Jin (Department of Nuclear Medicine, Chonbuk National University Medical School and Hospital)
Kim, Dong-Wook (Department of Nuclear Medicine, Chonbuk National University Medical School and Hospital)
Jeong, Hwan-Jeong (Department of Nuclear Medicine, Chonbuk National University Medical School and Hospital)
Sohn, Myung-Hee (Department of Nuclear Medicine, Chonbuk National University Medical School and Hospital)
Publication Information
Nuclear Medicine and Molecular Imaging / v.43, no.4, 2009 , pp. 357-360 More about this Journal
Abstract
Malignant mesothelioma of the peritoneum is a rare neoplasm with a rapidly fatal course. The tumour arises from the mesothelial cells lining the pleura and peritoneum or, rarely, in the pericardium or tunica vaginalis. This neoplasm is characterized by being difficult to diagnose, having a rapid evolution and a poor response to therapy. Mesothelioma is very glucose avid, and malignant pleural mesothelioma has been reported concerning the utility of F-18 FDG PET or PET/CT. But little has been known about the imaging finding of malignant peritoneal mesothelioma on F-18 FDG PET/CT. We report a case of malignant peritoneal mesothelioma mimicking peritoneal carcinomatosis of F-18 FDG PET/CT.
Keywords
Mesothelioma; peritoneum; F-18 fluorodeoxyglucose; PET/CT;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Loggie BW, Fleming RA, McQuellon RP, Russell GB, Geisinger KR, Levine EA. Prospective trial for the treatment of malignant peritoneal mesothelioma. Am Surg 2001;67:999-1003   PUBMED
2 Tandar A, Abraham G, Gurka J, Wendel M, Stolbach L. Recurrent peritoneal mesothelioma with long-delayed recurrence. J Clin Gastroenterol 2001;33:247-50   DOI   ScienceOn
3 Neumann V, Rutten A, Scharmach M, Muller KM, Fischer M. Factors influencing long-term survival in mesothelioma patients-results of the German mesothelioma register. Int Arch Occup Environ Health 2004;77:191-9   DOI   ScienceOn
4 Sheila Sheth, MD, Karen M. Horton, MD. Mesenteric neoplasms: CT appearances of primary and secondary tumors and differential diagnosis. Radiographics 2003;23:458-73   PUBMED
5 Sugarbaker PH, Acherman YI, Gonzalez-Moreno S, Ortega-Perez G, Stuart OA, Marchettini P, et al. Diagnosis and treatment of peritoneal mesothelioma: the Washington Cancer Institute experience. Semin Oncol 2002;29:51-61   DOI   PUBMED
6 Yamamoto M, Gerbaudo VH, Gill RR, jacobson FL, Sugarbaker DJ, Hatabu H. Morphologic and functional imaging of malignant pleural mesothelioma. Eur J Rad 2007;64;356-66   DOI   ScienceOn
7 Banayan S, Hot A, Janier M, Ninet J, Zurlinden O, Billotey C. Malignant mesothelioma of the peritoneum as the cause of a paraneoplastic syndrome: detection by $^{18}F$-FDG PET. Eur J Nucl Med Mol Imaging 2006;33:751   DOI   ScienceOn
8 Raptopoulos V. Peritoneal mesothelioma. Crit Rev Diagn Imaging 1985;24:293-328   ScienceOn
9 Acherman YI, Welch LS, Bromley CM, Sugarbaker PH. Clinical presentation of peritoneal mesothelioma. Tumori 2003;89:269-73   PUBMED   ScienceOn
10 Duan HJ, Itoh N, Tamagami O, Katsuyama T, Shigematus H. Diffuse malignant peritoneal mesothelioma in a young women with a high serum level of CA-125. Acta Pathol Jpn 1991;41:158-63
11 Flores RM, Akhurst T, Gonen M, Zakowski M, Dycoco K, Larson SM, et al. Positron emission tomography predicts survival in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2006;132:763-8   DOI   ScienceOn
12 Eade TN, Fulham MJ, Constable CJ. Primary malignant peritoneal mesothelioma: appearance on F-18 FDG positron emission tomographic images. Clin Nucl Med 2002;27:924-5   DOI   ScienceOn
13 James M. Busch, Jonathan B. Kruskal, Bryan Wu. Best cases from the AFIP: malignant peritoneal mesothelioma. Radiographies 2002;22:1511-5   DOI   PUBMED
14 Hamrick-Tumerr JE, Chiechi MV, Abbitt PL, Ros PR. Neoplastic and inflammatory processes of the peritoneum, omentum, and mesentery: diagnosis with CT. Radiographies 1992;12:1051-68   DOI   PUBMED
15 Antman K, Shemin R, Ryan L, Klegar K, Osteen R, Herman T, et al. Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985. J Clin Oncol 1988;6:147-53   DOI   PUBMED
16 Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province (Soufu Africa). Br J Ind Med 1960;17:260   ScienceOn
17 Brenner J, Sordillo PP, Magill GB, Golbey RB. Malignant peritoneal mesothelioma: review of 25 patients. Am J Gastroenterol 1981;75:311-3   PUBMED   ScienceOn
18 Simsek H, Kadayifci A, Okan E. Importance of serum CA-125 levels in malignant peritoneal mesothelioma. Tumor Biol 1996;17:1-4   PUBMED   ScienceOn